Compare TVS SRICHAKRA with Indoco Remedies - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TVS SRICHAKRA vs INDOCO REMEDIES - Comparison Results

INDOCO REMEDIES 
   Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TVS SRICHAKRA INDOCO REMEDIES TVS SRICHAKRA/
INDOCO REMEDIES
 
P/E (TTM) x 10.9 127.6 8.5% View Chart
P/BV x 1.8 2.1 85.7% View Chart
Dividend Yield % 2.3 0.6 359.3%  

Financials

 TVS SRICHAKRA   INDOCO REMEDIES
EQUITY SHARE DATA
    TVS SRICHAKRA
Mar-19
INDOCO REMEDIES
Mar-18
TVS SRICHAKRA/
INDOCO REMEDIES
5-Yr Chart
Click to enlarge
High Rs3,765317 1,186.2%   
Low Rs2,170178 1,218.4%   
Sales per share (Unadj.) Rs3,173.6113.1 2,806.8%  
Earnings per share (Unadj.) Rs134.84.5 3,018.3%  
Cash flow per share (Unadj.) Rs245.511.8 2,077.8%  
Dividends per share (Unadj.) Rs40.001.00 4,000.0%  
Dividend yield (eoy) %1.30.4 334.0%  
Book value per share (Unadj.) Rs950.773.2 1,298.0%  
Shares outstanding (eoy) m7.6692.15 8.3%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.92.2 42.7%   
Avg P/E ratio x22.055.5 39.7%  
P/CF ratio (eoy) x12.121.0 57.6%  
Price / Book Value ratio x3.13.4 92.3%  
Dividend payout %29.722.4 132.5%   
Avg Mkt Cap Rs m22,73022,830 99.6%   
No. of employees `0002.75.5 49.5%   
Total wages/salary Rs m2,8132,209 127.3%   
Avg. sales/employee Rs Th9,003.61,910.1 471.4%   
Avg. wages/employee Rs Th1,041.8405.0 257.3%   
Avg. net profit/employee Rs Th382.575.5 506.9%   
INCOME DATA
Net Sales Rs m24,31010,419 233.3%  
Other income Rs m12047 255.9%   
Total revenues Rs m24,43010,466 233.4%   
Gross profit Rs m2,6181,349 194.0%  
Depreciation Rs m848677 125.2%   
Interest Rs m357235 151.9%   
Profit before tax Rs m1,533484 316.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m50072 690.9%   
Profit after tax Rs m1,033412 250.9%  
Gross profit margin %10.812.9 83.1%  
Effective tax rate %32.615.0 218.1%   
Net profit margin %4.24.0 107.5%  
BALANCE SHEET DATA
Current assets Rs m9,2585,373 172.3%   
Current liabilities Rs m8,8154,157 212.1%   
Net working cap to sales %1.811.7 15.6%  
Current ratio x1.11.3 81.3%  
Inventory Days Days7568 110.5%  
Debtors Days Days5173 69.4%  
Net fixed assets Rs m6,9026,244 110.5%   
Share capital Rs m77184 41.6%   
"Free" reserves Rs m7,2066,566 109.8%   
Net worth Rs m7,2836,750 107.9%   
Long term debt Rs m4691,233 38.0%   
Total assets Rs m18,09312,363 146.3%  
Interest coverage x5.33.1 173.1%   
Debt to equity ratio x0.10.2 35.2%  
Sales to assets ratio x1.30.8 159.4%   
Return on assets %7.75.2 146.8%  
Return on equity %14.26.1 232.5%  
Return on capital %24.49.0 270.7%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2,4243,762 64.4%   
Fx outflow Rs m3,5501,143 310.5%   
Net fx Rs m-1,1272,619 -43.0%   
CASH FLOW
From Operations Rs m6401,227 52.2%  
From Investments Rs m-1,204-1,360 88.5%  
From Financial Activity Rs m524-388 -135.1%  
Net Cashflow Rs m-40-521 7.7%  

Share Holding

Indian Promoters % 45.4 59.2 76.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.6 12.5 20.8%  
FIIs % 0.0 6.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 52.1 22.4 232.6%  
Shareholders   23,740 12,805 185.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TVS SRICHAKRA With:   TALWALKARS BETTER VALUE  REDINGTON  NALWA SONS INV  BAJAJ FINANCE  JSW HOLDINGS  



Today's Market

Sensex Slumps 470 Points; Energy and Banking Stocks Witness Selling(Closing)

Indian share markets witnessed negative trading activity throughout the day and ended deep in the red. The BSE Sensex fell over 550 points intraday and breached the 36,000 mark.

Related Views on News

TVS SRICHAKRA 2018-19 Annual Report Analysis (Annual Result Update)

Aug 19, 2019 | Updated on Aug 19, 2019

Here's an analysis of the annual report of TVS SRICHAKRA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of TVS SRICHAKRA. Also includes updates on the valuation of TVS SRICHAKRA.

INDOCO REMEDIES Announces Quarterly Results (1QFY20); Net Profit Up 118.1% (Quarterly Result Update)

Aug 14, 2019 | Updated on Aug 14, 2019

For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 43.3% (Quarterly Result Update)

Jun 6, 2019 | Updated on Jun 6, 2019

For the quarter ended March 2019, INDOCO REMEDIES has posted a net profit of Rs 116 m (down 43.3% YoY). Sales on the other hand came in at Rs 3 bn (down 6.5% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

INDOCO REMEDIES 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of INDOCO REMEDIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of INDOCO REMEDIES. Also includes updates on the valuation of INDOCO REMEDIES.

INDOCO REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 76.4% (Quarterly Result Update)

Jan 24, 2019 | Updated on Jan 24, 2019

For the quarter ended December 2018, INDOCO REMEDIES has posted a net profit of Rs 53 m (down 76.4% YoY). Sales on the other hand came in at Rs 3 bn (down 5.6% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.

More Views on News

Most Popular

Buy these 7 Stocks if You Believe in India(The 5 Minute Wrapup)

Sep 12, 2019

News headlines predict gloom and doom for India these days. You should ignore them.

A Recession Proof Stock You Can Bet On(Profit Hunter)

Sep 10, 2019

Usually, the typical horizon period for my smallcap recommendations is 3 to 5 years. But if you ask me, this could be one business that you could own and pass on to future generations.

A Rare Opportunity to Buy the Top 5 Stocks in the Market(The 5 Minute Wrapup)

Sep 16, 2019

The stock market today is throwing up a great opportunity to pile on quality stocks.

This Company Will Do Well Despite the Slowdown(The 5 Minute Wrapup)

Sep 11, 2019

How financial inclusion provides a big runway for this stock recommendation.

The 5 Best Trading Opportunities I've Spotted(Profit Hunter)

Sep 13, 2019

These 10 auto stocks should be in your watchlist for the next 32 months. Paste them on your workstation NOW.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

TVS SRICHAKRA SHARE PRICE


Sep 19, 2019 (Close)

TRACK TVS SRICHAKRA

  • Track your investment in TVS SRICHAKRA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

TVS SRICHAKRA 5-YR ANALYSIS

COMPARE TVS SRICHAKRA WITH

MARKET STATS